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Abstract: Adipose tissue-derived microvascular fragments (ad-MVF) represent effective vascularisation
units for the seeding of dermal substitutes. However, particularly in case of extensive skin defects, the
required amounts of donor fat tissue for the harvesting of ad-MVF may not always be available. There-
fore, we herein determined the lowest ad-MVF density needed to induce a sufficient vascularisation and
incorporation of seeded implants. Collagen-glycosaminoglycan matrices (Integra®; diameter: 4 mm) were
seeded with 15,000 (HD), 10,000 (MD) and 5,000 (LD) ad-MVF and implanted into full-thickness skin
defects within mouse dorsal skinfold chambers, to analyse their in vivo vascularisation and incorporation.
Intravital fluorescence microscopy showed a comparable vascularisation of HD and MD ad-MVF-seeded
Integra®, which was significantly higher when compared to LD ad-MVF-seeded Integra®. As assessed
by photoacoustic imaging, this was associated with an increased oxygenation of the implants. Addi-
tional histological and immunohistochemical analyses revealed an enhanced cellular infiltration, collagen
content, microvessel density and epithelialisation of HD and MD ad-MVF-seeded Integra®, indicating a
better incorporation compared to LD ad-MVF-seeded implants. These findings demonstrate that 80,000
ad-MVF/cm² is the least required density to guarantee an effective vascularisation of the dermal substi-
tute.
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Abstract
Adipose tissue-derived microvascular fragments (ad-MVF) represent effective vascularisation units for the 
seeding of dermal substitutes. However, particularly in case of extensive skin defects, the required amounts of 
donor fat tissue for the harvesting of ad-MVF may not always be available. Therefore, we herein determined 
the lowest ad-MVF density needed to induce a sufficient vascularisation and incorporation of seeded implants. 
Collagen-glycosaminoglycan matrices (Integra®; diameter: 4 mm) were seeded with 15,000 (HD), 10,000 
(MD) and 5,000 (LD) ad-MVF and implanted into full-thickness skin defects within mouse dorsal skinfold 
chambers, to analyse their in vivo vascularisation and incorporation. Intravital fluorescence microscopy 
showed a comparable vascularisation of HD and MD ad-MVF-seeded Integra®, which was significantly higher 
when compared to LD ad-MVF-seeded Integra®. As assessed by photoacoustic imaging, this was associated 
with an increased oxygenation of the implants. Additional histological and immunohistochemical analyses 
revealed an enhanced cellular infiltration, collagen content, microvessel density and epithelialisation of 
HD and MD ad-MVF-seeded Integra®, indicating a better incorporation compared to LD ad-MVF-seeded 
implants. These findings demonstrate that 80,000 ad-MVF/cm² is the least required density to guarantee an 
effective vascularisation of the dermal substitute.
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imaging, dorsal skinfold chamber.
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Introduction
For the treatment of extensive skin defects, autologous 
split-thickness skin grafting (STSG) is the method of 
choice (Kneilling et al., 2011; Kanapathy et al., 2016). 
However, particularly deep burn wounds, that 
exceed 50-60 % of the total body surface, bear the risk 
of extensive scarring and donor site shortage for skin 
transplantation (MacNeil, 2007; Böttcher-Haberzeth 
et al., 2010; Shevchenko et al., 2010; Miyanaga et al., 
2016). Moreover, the destruction of dermal and 
subcutaneous layers in deep wounds complicates the 
initial application of STSG and increases the risk of 
infection due to the loss of the skin’s physiological 
barrier function.
 To overcome these problems, several acellular 
matrices, such as Dermagraft® (Organogenesis 
Inc.) or Integra® (Integra Life Sciences), have been 
bioengineered as off-the-shelf products for the 
initial coverage of extensive dermal defects (Zhong 
et al., 2010; Graham et al., 2013; Debels et al., 2015; 
Singer et al., 2015). As these dermal substitutes 
degrade over time, their porous structures not only 
provide mechanical support, but also promote 
cellular infiltration and vascular ingrowth from the 
surrounding host tissue, leading to a vascularised 
wound bed for the final coverage with STSG (Awad 
et al., 2000) after 3 weeks.
 Experimental  studies  indicate that  the 
incorporation of dermal substitutes is improved by the 
seeding with mesenchymal stem cells, keratinocytes 
and adipose tissue-derived microvascular fragments 
(ad-MVF) (Wisser and Steffes, 2003; Trottier et al., 
2008; Frueh et al., 2017a). Of interest, ad-MVF can 
be isolated in large amounts from fat tissue within 
a short time and represent fully functional vessel 
segments (Frueh et al., 2017b). Hence, they bear the 
major advantage that their reassembly into new 
microvascular networks induces a rapid implant 
vascularisation and blood perfusion (Laschke et al., 
2012; Laschke and Menger, 2015). For this purpose, 
angiogenic sprouts, growing out of the vessel 
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segments, have to develop interconnections (Nunes 
et al., 2010). Since the growth rate of such angiogenic 
sprouts is ~5 µm/h (Utzinger et al., 2015), the distance 
between individual ad-MVF crucially determines the 
kinetics of this network formation process (Später et 
al., 2017). These considerations suggest that a high 
seeding density of ad-MVF markedly contributes to 
the success of this vascularisation strategy. On the 
other hand, it should be noted that, particularly in 
case of large tissue defects, this would require large 
volumes of donor fat tissue, which may not always 
be available under clinical conditions.
 Taking this into account, the aim of the present 
experimental study was to determine the lowest 
ad-MVF density needed to develop a sufficient 
vascularisation and incorporation of seeded implants. 
For this purpose, we performed an in-depth 
analysis to assess the number of ad-MVF that can 
be isolated from 1 mL of epididymal fat tissue 
of donor mice in dependency of their age. In 
addition, collagen-glycosaminoglycan matrices 
(Integra®) were seeded with three different ad-MVF 
densities and subsequently implanted into full-
thickness skin defects within mouse dorsal skinfold 
chambers. Their vascularisation and incorporation 
was analysed throughout a 2-week observation 
period using intravital fluorescence microscopy, 




All animal experiments were approved by the 
local governmental animal care committee (permit 
number: 33/2016) and conducted in accordance with 
the European legislation on the protection of animals 
(Directive 2010/63/EU) and the National Institutes 
of Health (NIH) guidelines on the care and use of 
laboratory animals (NIH publication #85-23 Rev. 
1985).
 Dorsal skinfold chambers were implanted in 
wild-type C57BL/6 mice (Institute for Clinical 
and Experimental Surgery, Saarland University, 
Homburg, Germany), with an age of 4-6 months 
and a body weight of 24-28 g. Epididymal fat was 
isolated from male green fluorescent protein (GFP)+ 
mice [C57BL/6-Tg(CAG-EGFP)1Osb/J; The Jackson 
Laboratory, Bar Harbor, ME, USA], with an age of 
7-12 months and a body weight of > 30 g, to guarantee 
large epididymal fat pads containing sufficient 
amounts of ad-MVF for the seeding of the matrices 
(Grässer et al., 2016). The animals were housed under 
a 12 h light/dark cycle and received ad libitum water 
and standard food pellets (Altromin, Lage, Germany).
Isolation of ad-MVF
Ad-MVF were isolated from epididymal fat pads of 
GFP+ donor mice, as previously described in detail 
(Frueh et al., 2017b). Briefly, the bilateral epididymal 
fat pads were transferred into 10 % Dulbecco’s 
modified eagle medium (DMEM; 100 U/mL penicillin, 
0.1 mg/mL streptomycin; Biochrom, Berlin, Germany) 
and washed thrice with phosphate-buffered saline 
(PBS). Next, the isolated fat tissue was minced and 
digested for 10 min with collagenase NB4G (0.5 U/
mL; Serva, Heidelberg, Germany) under slow stirring 
and humidified atmospheric conditions (37 °C, 
5 % CO2). The digestion was neutralised with PBS 
supplemented with 20 % foetal calf serum (FCS) 
and the cell-vessel suspension was incubated at 
37 °C for 5 min. The fat supernatant was removed, 
the remaining suspension was filtered through a 
500 µm mesh and the GFP+ ad-MVF were enriched 
up to a pellet size by a 5 min centrifugation at 120 ×g. 
Subsequently, this ad-MVF pellet was either used for 
in vitro analyses or resuspended in 1 µL of 0.9 % NaCl 
for the seeding of the implants.
Quantification and length distribution of isolated 
ad-MVF
Donor mice for the isolation of ad-MVF were assigned 
to 6 age groups (7, 8, 9, 10, 11 and 12 months old). 
To correlate the parameters animal age, fat tissue 
volume and ad-MVF number and size, ad-MVF were 
isolated from the epididymal fat pads of 18 donor 
mice (n = 3 per group). After isolation, 10 % of the 
total cell-vessel suspension was diluted 1 : 10 in PBS 
and 100 µL of this dilution were transferred into a 
96-well plate to assess the number of ad-MVF by 
means of microscopic counting (Fig. 1a,b). The total 
number of ad-MVF was subsequently extrapolated to 
the whole isolate (Frueh et al., 2017b). Furthermore, 
the average ad-MVF length was measured by means 
of microscopic analysis.
Flow cytometry
To analyse the cellular composition of ad-MVF from 6 
donor age groups (7, 8, 9, 10, 11 and 12 months old) by 
means of flow cytometry, ad-MVF, isolated from 18 
male C57BL/6 mice (n = 3 per group), were digested 
for 30 min in Accutase® (BioLegend, Fell, Germany) 
to single cells. Then, the single cells were analysed 
for the expression of the monoclonal rat anti-mouse 
endothelial cell marker CD31-phycoerythrin (PE) (BD 
Biosciences, Heidelberg, Germany), the perivascular 
cell marker mouse anti-α-smooth muscle actin (SMA) 
(Thermo Fisher Scientific Inc., Waltham, MA, USA), 
the monoclonal stromal/stem cell surface markers rat 
anti-mouse CD117-fluorescein isothiocyanate (FITC) 
(BD Biosciences), the mouse anti-rat/mouse CD90-
FITC (BioLegend) and the hamster anti-rat/mouse 
CD29-FITC (BioLegend). Isotype identical rat IgG-PE 
or rat IgG-FITC (BD Biosciences), mouse IgG-FITC 
(BD Biosciences) and hamster IgG-FITC (BioLegend) 
served as controls. Additionally, cells were analysed 
for the expression of the purified polyclonal sheep 
anti-mouse/human adipocyte marker adipocyte-
specific adhesion molecule (ASAM) (R&D Systems, 
Wiesbaden, Germany), followed by a secondary 
donkey anti-sheep IgG-Alexa488 antibody (Molecular 
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Probes, Eugene, OR, USA). Flow cytometric analyses 
were performed, using a FACScan (BD Biosciences) 
and data were assessed using the software package 
Cell-Quest Pro (BD Biosciences).
Seeding of Integra®
A 4 mm biopsy punch (kaiEurope GmbH, Solingen, 
Germany) was used to cut 12.6 mm2 identical 
implants out of a 1.3 mm thick Integra® dermal 
regeneration template single layer without silicone 
sheet (Integra Life Sciences, Ratingen, Germany). The 
samples (Fig. 1c) were placed on a 500 µm cell strainer 
and 15 µL of 0.9 % NaCl, containing a high density 
(HD) of ~15,000 ad-MVF, a medium density (MD) 
of ~10,000 ad-MVF or a low density (LD) of ~5,000 
ad-MVF (Fig. 1d), were transferred onto the implants 
with a 20 µL pipette (Eppendorf, Wesseling-Berzdorf, 
Germany). Noteworthy, the used ad-MVF seeding 
density of the HD group was identical to that applied 
in previous studies (Frueh et al., 2017a).
Modified dorsal skinfold chamber model
According to Sorg et al. (2007; 2009), a modified 
dorsal skinfold chamber model was used for the in 
vivo analysis of ad-MVF-seeded implants (Fig. 1e). 
For the implantation of the dorsal skinfold chamber 
(Irola Industriekomponenten GmbH & Co. KG, 
Schonach, Germany), the mice were anaesthetised 
by intraperitoneal injection of ketamine (75 mg/kg 
body weight; Ursotamin®; Serumwerke Bernburg, 
Bernburg, Germany) and xylazine (15 mg/kg body 
weight; Rompun®; Bayer, Leverkusen, Germany). 
Fig. 1. Freshly isolated (a, arrows) ad-MVF from the epididymal fat pads of donor mice. Higher 
magnification (b = insert in a) reveals a typical tube-like vessel morphology. Scale bars: a = 100 µm; 
b = 15 µm. (c) Integra® directly after sample preparation. Scale bar: 1.5 mm. (d) The samples were seeded 
with a high density (HD), medium density (MD) and low density (LD) of ad-MVF. (e) C57BL/6 mouse 
with a dorsal skinfold chamber. Scale bar: 12 mm. (f) Schematic cross-section of a dorsal skinfold chamber 
preparation with a full-thickness skin defect filled with ad-MVF-seeded Integra® (implant). The observation 
window provided direct access to the implant for repetitive intravital fluorescence microscopy, whereas 
ultrasound and photoacoustic imaging was performed from the backside of the chamber, which was 
covered with a PVC mask to prevent noise signal originating from the titanium frame. (g,h) Backside 
titanium frame of the chamber covered with a PVC mask (arrows = gaps for screws of the titanium frame; 
asterisk = opening for photoacoustic imaging). Scale bars: g = 10 mm, h = 6 mm.
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Then, the two symmetrical titanium frames were 
fixed on the extended dorsal skinfold, as described 
previously in detail (Laschke and Menger, 2016). 
After a 48 h recovery period, the mice were 
anaesthetised again and a 4 mm full-thickness skin 
defect was created within the observation window 
of the chamber using a dermal biopsy punch 
(kaiEurope GmbH) and microsurgical instruments. 
Subsequently, the defect was filled with ad-MVF-
seeded Integra® before the observation window of 
the chamber was sealed with a removable cover 
glass (Fig. 1f).
Stereomicroscopy
To assess the epithelialisation of ad-MVF-seeded 
Integra®, as well as the implant-induced degree 
of haemorrhage by planimetry, the anaesthetised 
animals were fixed on a Plexiglas® stage and the 
dorsal skinfold chamber was positioned under a 
stereomicroscope (Leica M651, Wetzlar, Germany) 
on day 0 (day of implantation), 3, 6, 10 and 14. The 
chamber tissue was visualised in epi-illumination to 
identify epithelialised and non-epithelialised implant 
areas. Furthermore, trans-illumination was used to 
evaluate the extent of bleeding induced by implanted 
HD, MD and LD ad-MVF-seeded Integra® (given in % 
of implant surface) by means of a semi-quantitative 
haemorrhagic score as follows: 1: no bleeding, 2: 
1-25 %, 3: 26-50 %, 4: 51-75 %, 5: 76-100 %, 6: bleeding 
exceeding implant surface. The microscopic images 
were recorded by a DVD system and analysed 
using the CapImage computer-assisted off-line 
analysis system (Zeintl, Heidelberg, Germany). The 
epithelialised area (given in %) was calculated by 
the equation: (total implant area − non-epithelialised 
implant area) / (total implant area) × 100 (Später et 
al., 2016).
Intravital fluorescence microscopy
After stereomicroscopy, 0.1 mL of the blood plasma 
marker FITC-labelled dextran (5 %; 150,000 Da; Sigma-
Aldrich, Taufkirchen, Germany) was retrobulbarily 
injected into the venous plexus of the anaesthetised 
animals for contrast enhancement. The observation 
window of the chamber was positioned under a Zeiss 
Axiotech fluorescent microscope (Zeiss, Oberkochen, 
Germany) and the microscopic images were recorded 
by a charge-coupled device video camera (FK6990; 
Pieper, Schwerte, Germany) and a DVD system for 
off-line analyses (Laschke et al., 2015).
 The analysis of the microscopic images 
was performed using CapImage (Zeintl). The 
vascularisation of the implants was assessed in 12 
regions of interest (ROIs). ROIs exhibiting red blood 
cell (RBC)-perfused microvessels were defined and 
counted as perfused ROIs (in % of all ROIs) (Später 
et al., 2017). The functional microvessel density was 
determined as the total length of all RBC-perfused 
microvessels per ROI (cm/cm2). In addition, the 
diameter (d, in µm) and centreline RBC velocity (v, 
µm/s) of 40 randomly selected microvessels were 
measured. Subsequently, these two parameters were 
used to calculate the wall shear rate (y, in s-1) by means 
of the Newtonian definition y = 8 × v/d (Ampofo et 
al., 2016).
Ultrasound and photoacoustic imaging
Ultrasound and photoacoustic imaging was used 
to detect haemoglobin oxygen saturation (sO2) in 
OxyHemo-mode within HD, MD and LD ad-MVF-
seeded Integra® by using a Vevo LAZR system 
(FUJIFILM VisualSonics Inc., Toronto, ON, Canada) 
and a real-time microvisualisation LZ550 linear-array 
transducer (FUJIFILM VisualSonics Inc.) with a centre 
frequency of 40 MHz.
 For in vitro analyses, freshly-seeded, non-
implanted Integra® samples were embedded in 
ultrasound gel (Aquasonic 100; Parker, Fairfield, 
NJ, USA) to prevent interference with ultrasound 
coupling. For the in vivo analysis of implanted 
Integra® on day 14, the chamber-equipped animals 
were anaesthetised with 1.5 % isofluorane in air and 
subsequently fixed in prone position on a heated 
stage. Heart rate and breathing rate were constantly 
monitored and the body temperature was maintained 
at 37 °C (THM100; Indus Instruments, Houston, 
TX, USA). To prevent noise signal originating from 
the titanium frames, the dorsal skinfold chamber 
was covered with a 3 mm soft polyvinyl chloride 
(PVC) mask (Fig. 1g,h; Sagustu International 
GmbH, Bruchmühlbach-Miesau, Germany) and the 
depilated skin, within the backside of the observation 
window, was covered with ultrasound gel to avoid 
air interference with ultrasound coupling into the 
animal.
 For three-dimensional, high-resolution B-mode 
ultrasound and OxyHemo-mode photoacoustic 
image acquisition, the scanhead was driven by a linear 
motor to acquire two-dimensional images at regular 
spatial intervals, parallel and uniformly spaced at 
150 μm intervals over the entire implant diameter. 
OxyHemo-mode photoacoustic images were taken at 
750 nm and 850 nm with a two-dimensional gain of 
34 dB (in vitro) and 32 dB (in vivo) to detect sO2 within 
the samples (Mallidi et al., 2015; Rich and Seshadri, 
2015). All values were acquired using the Vevo LAB 
1.7.2. software (FUJIFILM VisualSonics Inc.).
Experimental protocol
In a first set of experiments, the volume of the excised 
epididymal fat tissue from the 18 GFP+ donor mice of 
the 6 different age groups (7, 8, 9, 10, 11 and 12 months 
old; n = 3 per group) was quantified. Subsequently, 
both the number of ad-MVF per mL fat tissue, as 
well as, the ad-MVF length were assessed by means 
of microscopic analysis. The cellular composition of 
ad-MVF after isolation was investigated by additional 
flow cytometric analyses.
 For in vivo analyses, ad-MVF were harvested 
from the epididymal fat tissue of 8 GFP+ donor mice. 
The isolated ad-MVF were divided into 3 different 
density groups (HD: ~15,000 ad-MVF; MD: ~10,000 
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ad-MVF; LD: ~5,000 ad-MVF) and subsequently 
seeded on Integra® (n = 8 per group). The seeded 
matrices were implanted into full-thickness skin 
defects within dorsal skinfold chambers of 24 GFP- 
wild-type C57BL/6 recipient animals. Vascularisation, 
incorporation, epithelialisation and bleeding of 
the implants were analysed by means of repetitive 
stereomicroscopy and intravital fluorescence 
microscopy on day 0 (day of implantation), 3, 6, 
10 and 14. Finally, ultrasound and photoacoustic 
imaging of 3 implants per group was performed on 
day 14. Thereafter, the animals were sacrificed with 
an overdose of anaesthesia and the dorsal skinfold 
chamber preparations were processed for histological 
and immunohistochemical analyses.
Histology and immunohistochemistry
Formalin-fixed samples of the dorsal skinfold 
preparations with the implants were embedded 
in paraffin and subsequently cut into 3 µm-thick 
sections. Haematoxylin and eosin (HE) staining 
of individual sections was performed according 
to standard procedures. In addition, the reddish 
appearance, under polarised light, of mature sirius 
red-stained collagen type I fibres was used to quantify 
the collagen content of implanted ad-MVF-seeded 
Integra®. The collagen content was assessed in relation 
to normal skin in 4 central ROIs for each sample using 
a BX60 microscope (Olympus, Hamburg, Germany) 
and the imaging software cellSens Dimension 1.11 
(Olympus) (Frueh et al., 2017a).
 Additional sections were co-stained using a 
monoclonal rat anti-mouse antibody against the 
endothelial cell marker CD31 (1 : 100; Dianova, 
Hamburg, Germany) and a polyclonal goat antibody 
against GFP (1 : 200; Rockland Immunochemicals, 
Limerick, PA, USA) while a goat anti-rat IgG Alexa555 
(1 : 200; Life Technologies, Ober-Olm, Germany) and 
a biotinylated donkey anti-goat antibody (1 : 30; 
Dianova) served as secondary antibodies. The 
biotinylated antibody was detected by streptavidin-
Alexa488 (1 : 50; Life Technologies) and cell nuclei 
were stained with Hoechst 33342 (1 : 500; Sigma-
Aldrich). The density of CD31+ microvessels (given 
in mm-2) and the fraction of CD31+/GFP+ microvessels 
(given in %) were quantitatively analysed within the 
implants.
 For the immunohistochemical detection of the 
cytokeratin+ epithelial layer, covering the implanted 
Integra® on day 14, sections of the largest cross-
sectional diameter of the matrices were incubated 
with a rabbit polyclonal anti-cytokeratin antibody 
(1 : 100; Abcam, Cambridge, UK), as primary 
antibody, followed by a biotinylated goat anti-
rabbit IgG antibody (ready-to-use; Abcam). The 
biotinylated antibody was detected by peroxidase-
labelled-streptavidin (1 : 50; Sigma-Aldrich) and 
3,3-diaminobenzidine (Sigma-Aldrich) was used as 
chromogen. Using a BZ-8000 microscopic system 
(Keyence, Osaka, Japan), the length of the cytokeratin+ 
epithelial layer and the diameter of the implants 
were measured to assess epithelialisation as: length 
Fig. 2. (a) Volume of available epididymal adipose tissue (in mL per animal), (b) number of isolated 
ad-MVF (per mL adipose tissue) and (c) average ad-MVF length (µm) from 7, 8, 9, 10, 11 and 12 months 
old GFP+ donor mice (n = 3 per group). Mean ± SEM. (d) Length distribution of ad-MVF (%) from 7-12 
months old GFP+ donor mice (n = 18). Mean ± SEM.
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of cytokeratin+ epithelial layer / total diameter of 
implant × 100.
 For the immunohistochemical detection of 
myeloperoxidase (MPO)+ neutrophilic granulocytes, 
CD68+ macrophages and CD3+ lymphocytes, sections 
were incubated with a rabbit polyclonal anti-MPO 
antibody (1 : 100; Abcam), a rabbit polyclonal anti-
CD68 antibody (1 : 50; Abcam) and a rabbit polyclonal 
anti-CD3 antibody (1 : 100; Abcam), as primary 
antibodies, followed by a biotinylated goat anti-rabbit 
IgG antibody (ready-to-use; Abcam). The biotinylated 
antibody was detected by peroxidase-labelled-
streptavidin (1 : 50; Sigma-Aldrich). 3-Amino-9-
ethylcarbazole (Abcam) was used as chromogen. The 
sections were counterstained with Mayer’s haemalum 
(Merck, Darmstadt, Germany) and the number of 
immune cells (given in mm-2) was quantitatively 
assessed in 6 ROIs per section by light microscopy 
(BX60).
Statistical analysis
After testing the data for normal distribution and 
equal variance, differences between the groups 
were analysed by ANOVA followed by the Student-
Newman-Keuls post hoc test. In case of non-parametric 
data, differences were assessed by ANOVA on Ranks, 
followed by the Dunn’s post hoc test (SigmaPlot 11.0; 
Jandel Corporation, San Rafael, CA, USA). All values 
were expressed as mean ± standard error of the mean 
(SEM). Statistical significance was accepted for a 
value of p < 0.05.
Results
Quantification, length distribution and cellular 
composition of ad-MVF
There were no significant differences in the available 
volume of epididymal adipose tissue from donor 
mice in the age range of 7-12 months (Fig. 2a). In all 
analysed groups, ~1.4 mL adipose tissue could be 
harvested for the subsequent isolation of ad-MVF. 
From this amount of tissue, an overall number of 
~40,000 ad-MVF per mL with an average length of 
~40 µm could be enzymatically isolated (Fig. 2b,c). 
More detailed analyses revealed that 73 % of the 
isolated ad-MVF from all 6 age groups exhibited 
a length of 21-50 µm (Fig. 2d). Additional flow 
cytometric analyses showed a comparable cellular 
composition of ad-MVF from the donor animals 
of the different ages (Table 1). Ad-MVF typically 
contained ~25 % CD31+ endothelial cells, ~17 % 
α-SMA+ perivascular cells, ~ 8 % ASAM+ adipocytes, 
as well as, ~51 %, ~8 % and ~8 % cells expressing the 
stromal/stem cell surface markers CD29, CD90 and 
CD117, respectively (Table 1).
Vascularisation of ad-MVF-seeded implants
To analyse the in vivo vascularisation of HD, MD 
and LD ad-MVF-seeded Integra®, a modified dorsal 
skinfold chamber model was used. This allowed 
for the repetitive visualisation and quantitative 
analysis of microvascular network formation by 
means of intravital fluorescence microscopy (Fig. 
3a-i). The analyses revealed that the seeded ad-MVF 
were capable of developing interconnections with 
the surrounding host microvasculature of the full-
thickness skin defects. This resulted in the onset of 
blood perfusion within the implanted matrices on 
day 6 (Fig. 3j). Throughout the following observation 
period, the density of perfused microvessels 
progressively increased (Fig. 3k). This was associated 
with typical signs of vascular maturation and 
remodelling, i.e. decrease of diameters, as well as, 
increase of centreline RBC velocities and wall shear 
rates of individual microvessels (Table 2). Of interest, 
this vascularisation process was comparable in the 
groups of HD and MD ad-MVF-seeded Integra® 
without significant differences in all measured 
morphological and microhaemodynamic parameters 
(Fig. 3j,k; Table 2). In contrast, LD ad-MVF-seeded 
matrices exhibited a reduced vascularisation with 
a lower number of perfused ROIs and functional 
microvessel density between day 6 and 14 after 
implantation (Fig. 3j,k).
 Of interest, the vascularisation process also 
included haemorrhagic bleeding within the 
implants (Fig. 4a-g), which correlated with the 
extent of vascularisation and could be particularly 
observed during the phase of microvascular network 
development. Accordingly, HD and MD ad-MVF-
seeded Integra® exhibited elevated haemorrhagic 
scores on day 6 and 10, when compared to LD ad-
MVF-seeded implants (Fig. 4g).
Age 
(months) CD31 α-SMA ASAM CD29 CD90 CD117
7 30.0 ± 1.8 16.1 ± 1.4  9.1 ± 0.9  48.3 ± 3.6  9.1 ± 1.0 7.9 ± 0.6
8 27.4 ± 1.6 19.8 ± 1.8  5.1 ± 0.3  51.0 ± 2.5 7.2 ± 1.1 6.4 ± 1.1
9 25.7 ± 0.9 15.5 ± 1.6  7.8 ± 1.0  50.3 ± 3.7 7.1 ± 0.5 7.2 ± 0.6
10 23.9 ± 5.1 14.8 ± 2.5  9.7 ± 1.7  57.7 ± 2.8 9.8 ± 1.4 10.8 ± 1.5
11 20.8 ± 0.5 16.4 ± 2.1  8.4 ± 0.5  44.9 ± 5.1 8.0 ± 0.8 6.9 ± 0.7
12 24.7 ± 4.7 20.1 ± 1.7  6.6 ± 1.7  51.2 ± 7.4 7.9 ± 1.2 8.6 ± 1.9
Table 1. Cellular expression (%) of CD31, α-SMA, ASAM, CD29, CD90 and CD117 in ad-MVF isolated 
from the epididymal fat pads of 7-12 months old GFP+ donor mice (n = 3 per group), as assessed by flow 
cytometric analysis. Results are shown as mean ± SEM.
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Fig. 3. (a-i) Intravital fluorescence microscopy (blue light epi-illumination, contrast enhancement by 
5 % FITC-labelled dextran) of (a,d,g) HD, (b,e,h) MD and (c,f,i) LD ad-MVF-seeded Integra® on day 
14 after implantation into full-thickness skin defects within dorsal skinfold chambers of C57BL/6 mice 
(a-c: overview of chamber observation window; d-f: higher magnification of inserts in a-c; g-i: higher 
magnification of inserts in d-f). Note that the HD and MD ad-MVF-seeded implants exhibit a higher 
vascularisation when compared to the LD ad-MVF-seeded implant. Scale bars: a-c = 2.2 mm; d-f = 500 µm; 
g-i = 125 µm. (j) Perfused ROIs (%) and (k) functional microvessel density (cm/cm²) of HD (black circles, 
n = 8), MD (grey circles, n = 8) and LD (white circles, n = 8) ad-MVF-seeded Integra®, as assessed by 
intravital fluorescence microscopy and computer-assisted image analysis. Means ± SEM. * p < 0.05 vs. 
HD ad-MVF-seeded Integra®; # p < 0.05 vs. MD ad-MVF-seeded Integra®.
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Table 2. Diameter (µm), centreline RBC velocity (µm/s) and wall shear rate (s-1) of microvessels in HD 
(n = 8), MD (n = 8) and LD (n = 8) ad-MVF-seeded Integra®, as assessed by intravital fluorescence microscopy 
and computer-assisted image analysis. Results are shown as mean ± SEM.
d 0 d 3 d 6  d 10  d 14
Diameter [µm]:
HD - - 31.5 ± 1.0 23.5 ± 1.7 17.2 ± 1.2
MD - - 31.7 ± 1.8 24.1 ± 1.5 19.5 ± 1.4
LD - - 28.9 ± 0.5 22.5 ± 0.6 21.2 ± 0.9
Centreline RBC velocity [µm/s]:  
HD                            - - 229.2 ± 51.0 450.5 ± 58.5 497.6 ± 78.9
MD                            - - 176.2 ± 53.5 419.6 ± 78.3 438.8 ± 100.9
LD                            - - 148.1 ± 50.7 302.5 ± 36.1 392.4 ± 66.8
Wall shear rate [s-1]:  
HD - 58.8 ± 13.0 141.0 ± 17.8 243.2 ± 47.8
MD - 42.6 ± 11.8 137.5 ± 20.6 187.9 ± 45.1
LD                  - 107.6 ± 12.8 151.2 ± 30.3 151.2 ± 30.3
 In addition, ad-MVF-seeded matrices were 
analysed by means of ultrasound and photoacoustic 
imaging, which allowed for the evaluation of the 
samples’ oxygenation. In line with the different 
seeding densities, sO2 levels were highest in freshly 
HD ad-MVF-seeded, non-implanted matrices (Fig. 
5a-g). After the 14 d vascularisation period within the 
dorsal skinfold chamber model, LD ad-MVF-seeded 
Integra® exhibited significantly lower sO2 levels when 
compared to HD ad-MVF-seeded samples (Fig. 5h-
n). Noteworthy, there were no significant differences 
between HD and MD ad-MVF-seeded implants (Fig. 
5n).
Incorporation and immune cell infiltration of ad-
MVF-seeded implants
At the end of the 14 d observation period, histological 
and immunohistochemical analyses were performed 
to study the incorporation of the ad-MVF-seeded 
implants. HE-stained sections of LD ad-MVF-seeded 
Integra® exhibited a dense vascularised granulation 
tissue within the border zones, whereas the centre 
of the implants only contained a few single cells 
(Fig. 6e,f). In contrast, in HD and MD ad-MVF-
seeded implants a dense tissue infiltration could not 
exclusively be observed in the border but also in the 
centre zones (Fig. 6a-d). The analysis of sirius red-
stained sections revealed that LD ad-MVF-seeded 
Integra® contained significantly less collagen fibres 
when compared to HD and MD ad-MVF-seeded 
samples (Fig. 6g-k). Taken together, these findings 
indicated an insufficient incorporation of LD ad-
MVF-seeded implants into the surrounding host 
tissue.
 In line with our intravital fluorescent microscopic 
results, the density of CD31+ microvessels was 
significantly lower in LD ad-MVF-seeded Integra® 
when compared to HD and MD ad-MVF-seeded 
matrices (Fig. 6l-o). Of interest, CD31+/GFP+ co-
staining on day 14 demonstrated that ~90 % of all 
detected microvessels in HD, MD and LD ad-MVF-
seeded implants originated from GFP+ ad-MVF (Fig. 
6p-s). Additional immunohistochemical stainings 
revealed that the implants were infiltrated with MPO+ 
neutrophilic granulocytes, CD68+ macrophages and, 
to a smaller extent, CD3+ lymphocytes (Fig. 7a-l). 
In accordance with their overall reduced cellular 
infiltration, LD ad-MVF-seeded matrices contained 
significantly smaller numbers of these immune cell 
subpopulations when compared to the HD and MD 
ad-MVF-seeded implants (Fig. 7j-l).
Epithelialisation of the ad-MVF-seeded implants
The continuous access to the ad-MVF-seeded matrices 
through the observation window of the dorsal skinfold 
chamber allowed for the repetitive stereomicroscopic 
analysis of implant epithelialisation (Fig. 8a-f). 
HD and MD ad-MVF-seeded Integra® exhibited a 
comparable epithelialisation over time while the 
epithelialised surface of LD ad-MVF-seeded Integra® 
was significantly less on days 10 and 14 (Fig. 8g). 
Immunohistochemical analyses on day 14 confirmed 
these findings. Only ~57 % of LD ad-MVF-seeded 
Integra® were covered with a cytokeratin+ epithelial 
layer, whereas the cytokeratin+ epithelial coverage 
of HD and MD ad-MVF-seeded implants was ~75 % 
(Fig. 8h-k).
Discussion
Autologous STSG is the gold standard for the 
coverage of excised burn wounds (Supp et al., 2005; 
Kneilling et al., 2011; Kanapathy et al., 2016). For 
this purpose, a well-vascularised wound bed is an 
indispensable requirement (Schultz et al., 2003). 
In a promising experimental approach, we could 
recently demonstrate that this can be achieved by the 
implantation of ad-MVF-seeded dermal substitutes, 
which induce the formation of new microvascular 
networks at the defect site (Frueh et al., 2017a). In 
fact, seeding of ~120,000 ad-MVF/cm² Integra®, 
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Fig. 4. (a-f) Transillumination stereomicroscopy 
of implanted ad-MVF-seeded Integra® within 
the dorsal skinfold chamber of C57BL/6 mice 
displaying different manifestations of implant-
induced bleedings according to the semi-
quantitative haemorrhagic score, i.e. 1: no 
bleeding (a), 2: 1-25 % (b), 3: 26-50 % (c), 4: 51-75 % 
(d), 5: 76-100 % (e), 6: bleeding exceeding implant 
surface (f). Scale bars: 1.3 mm. (g) Haemorrhagic 
score of HD (black circles, n = 8), MD (grey circles, 
n = 8) and LD (white circles, n = 8) ad-MVF-seeded 
Integra®, as assessed by stereomicroscopy and 
computer-assisted image analysis. Means ± SEM. 
* p < 0.05 vs. HD ad-MVF-seeded Integra®.
Fig. 5. (a,c,e) B-mode ultrasound and (b,d,f) OxyHemo-mode photoacoustic imaging of (a,b) HD,(c,d) 
MD and (e,f) LD ad-MVF-seeded Integra® directly after the seeding procedure (b,d,f; red areas = high 
oxygenation, blue areas = low oxygenation). Scale bars: 600 µm. (g) sO2 (%) within freshly HD (black 
bar, n = 3), MD (grey bar, n = 3) and LD (white bar, n = 3) ad-MVF-seeded Integra®. Means ± SEM. (h,j,l) 
B-mode ultrasound and (i,k,m) OxyHemo-mode photoacoustic imaging of (h,i) HD, (j,k) MD and (l,m) 
LD ad-MVF-seeded Integra® on day 14 after implantation into full-thickness skin defects within dorsal 
skinfold chambers of C57BL/6 mice (l,k,m; red areas = high oxygenation, blue areas = low oxygenation). 
Scale bars: 600 µm. (n) sO2 (%) within HD (black bar, n = 3), MD (grey bar, n = 3) and LD (white bar, n = 3) 
ad-MVF-seeded Integra® on day 14 after implantation. Means ± SEM. * p < 0.05 vs. HD ad-MVF-seeded 
Integra®.
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Fig. 6. HE-stained sections of (a,b) HD,(c,d) MD and (e,f) LD ad-MVF-seeded Integra® on day 14 after 
implantation into full-thickness skin defects within dorsal skinfold chambers of C57BL/6 mice (broken line 
= implant border; asterisks = border zones; arrows = panniculus carnosus muscle; b,d,f = inserts in a,c,e). 
Scale bars: a,c,e = 200 µm; b,d,f = 50 µm. (g-j) Polarised light microscopy of sirius red-stained sections of (g) 
normal skin, as well as, (h) HD, (i) LM and (j) LD ad-MVF-seeded Integra® on day 14 after implantation. 
Scale bars = 45 µm. (k) Total collagen ratio (implant/skin) within HD (black bar, n = 8), MD (grey bar, n = 8) 
and LD (white bar, n = 8) ad-MVF-seeded Integra®. Means ± SEM. * p < 0.05 vs. HD ad-MVF-seeded Integra®; 
# p < 0.05 vs. MD ad-MVF-seeded Integra®. (l-n) Immunohistochemical detection of CD31+ microvessels 
(arrows) in (l) HD, (m) MD and (n) LD ad-MVF-seeded Integra® on day 14 after implantation. Scale bars 
= 45 µm. (o) Microvessel density (mm-2) within HD (black bar, n = 8), MD (grey bar, n = 8) and LD (white 
bar, n = 8) ad-MVF-seeded Integra® on day 14 after implantation. Means ± SEM. * p < 0.05 vs. HD ad-MVF-
seeded Integra®; # p < 0.05 vs. MD ad-MVF-seeded Integra®. (p-r) Immunohistochemical detection of CD31+/
GFP+ microvessels (arrows) in a HD ad-MVF-seeded implant (arrowheads = CD31+/GFP- microvessels). Scale 
bars: 45 µm. (s) GFP+ microvessels (%) within HD (black bar, n = 8), MD (grey bar, n = 8) and LD (white bar, 
n = 8) ad-MVF-seeded Integra® on day 14 after implantation. Means ± SEM.
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Fig. 7. Immunohistochemical detection of (a-c; arrows) MPO+ neutrophilic granulocytes, (d-f; arrows) CD68+ 
macrophages and (g-i; arrows) CD3+ lymphocytes in (a,d,g) HD, (b,e,h) MD and (c,f,i) LD ad-MVF-seeded 
Integra® on day 14 after implantation into full-thickness skin defects within dorsal skinfold chambers of 
C57BL/6 mice. Scale bars = 24 µm. (j) MPO+ neutrophilic granulocytes (mm-2), (k) CD68+ macrophages 
(mm-2) and (l) CD3+ lymphocytes (mm-2) within HD (black bars, n = 8), MD (grey bars, n = 8) and LD 
(white bars, n = 8) ad-MVF-seeded Integra® on day 14 after implantation. Means ± SEM. * p < 0.05 vs. HD 
ad-MVF-seeded Integra®; # p < 0.05 vs. MD ad-MVF-seeded Integra®.
corresponding to the HD ad-MVF-seeded group of 
the present study, resulted in a rapid vascularisation 
and incorporation of the matrix after implantation 
into full-thickness skin defects (Frueh et al., 2017a). 
However, particularly in case of massive burn injuries 
affecting large surface areas of the body (Supp et al., 
2005), the available amount of donor fat tissue for 
the isolation of ad-MVF may be limited. Taking this 
into account, our novel results demonstrated that a 
markedly reduced number of ~80,000 ad-MVF/cm² 
Integra®, corresponding to the MD ad-MVF-seeded 
group, still allowed for a sufficient vascularisation 
and incorporation of the dermal substitute. In 
contrast, reducing the number to 40,000 ad-MVF/cm² 
Integra®, corresponding to the LD ad-MVF-seeded 
group, resulted in an insufficient vascularisation and 
incorporation, as indicated by the lack of a dense 
vascularised granulation tissue in the centre of the 
substitute.
 To guarantee the seeding of Integra® with well-
defined ad-MVF densities, we first clarified whether 
individual mice markedly differ in terms of the 
amount of available epididymal adipose tissue and 
ad-MVF. We found that there were no significant 
differences between donor animals in the age range of 
7-12 months. In addition, the isolated ad-MVF had a 
comparable average length and cellular composition. 
Of interest, the ad-MVF did not only contain CD31+ 
endothelial cells and α-SMA+ perivascular cells, but 
also cells expressing the stem cell surface markers 
CD90 and CD117, which have been reported to 
exhibit a high regenerative and angiogenic potential 
(Li et al., 2003; Li et al., 2005; Oishi and Ito-Dufros, 
2006).
 Ad-MVF seeded matrices were implanted into full-
thickness skin defects within modified dorsal skinfold 
chambers. This approach provided deep insights 
into the vascularisation and incorporation process 
of the implants by combining sophisticated, non-
invasive in vivo imaging technologies with additional 
histological and immunohistochemical analyses. 
Using intravital fluorescence microscopy, we found 
that HD and MD ad-MVF-seeded Integra® exhibited 
a comparable vascularisation over time, whereas 
LD ad-MVF-seeded implants were characterised by 
a significantly lower number of perfused ROIs and 
functional microvessel density. In line with these 
findings, additional photoacoustic measurements 
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revealed lower sO2 levels within LD ad-MVF-seeded 
matrices on day 14 after implantation. Under clinical 
conditions, this reduced oxygenation may impair the 
engraftment of STSG. Taken together, these results 
clearly demonstrated that the seeding density isa 
crucial determinant for the in vivo vascularisation 
capacity of ad-MVF and their regenerative potential.
 A high seeding density of ad-MVF promotes 
their reassembly into new microvascular networks 
(Später et al., 2017). This process not only involves 
the interconnection of individual ad-MVF with each 
other but also the development of anastomoses 
with the surrounding vessels of the host tissue. The 
latter mechanism results in the early onset of blood 
perfusion, while the newly forming microvascular 
networks within the ad-MVF-seeded implants 
have not been fully established yet and, thus, are 
characterised by an increased leakage of blood. In line 
with this view, the formation of haemorrhages within 
the implants of all three groups was most pronounced 
between day 6 and 10. Moreover, the delayed onset 
of blood perfusion in LD ad-MVF-seeded matrices 
was associated with less bleedings on day 6. On 
day 14, the extent of haemorrhages decreased again. 
This can be explained by a progressive stabilisation 
and maturation of the microvascular networks, 
as indicated by decreased diameters, as well as, 
increased centreline RBC velocities and wall shear 
rates of individual microvessels over time (Laschke 
et al., 2006).
 Additional immunohistochemical analyses on day 
14 showed that the pores of the centre of both HD 
and MD ad-MVF-seeded implants were filled with a 
vascularised granulation tissue, whereas the LD ad-
MVF-seeded matrices mainly contained infiltrating 
single cells. As expected, LD ad-MVF-seeded 
implants also exhibited a significantly lower density 
of CD31+ microvessels. However, the fraction of GFP+ 
Fig. 8. Stereomicroscopic images displaying the epithelialisation of implanted (a,d) HD, (b,e) MD and (c, f) 
LD ad-MVF-seeded Integra® (a-c) directly, as well as, (d-f) on day 14 after implantation. Scale bars: 750 µm. 
(g) Epithelialisation (% of total implant surface) of HD (black circles, n = 8), MD (grey circles, n = 8) and 
LD (white circles, n = 8) ad-MVF-seeded Integra®, as assessed by planimetric analysis of stereomicroscopic 
images. Means ± SEM. * p < 0.05 vs. HD ad-MVF-seeded Integra®; # p < 0.05 vs. MD ad-MVF-seeded Integra®. 
Immunohistochemical detection of the cytokeratin+ epithelial layer (arrows) covering (h) HD, (i) MD and 
(j) LD ad-MVF-seeded Integra® on day 14. Scale bars = 0.8 mm. (k) Epithelialisation (% of total implant 
diameter) of HD (black bar, n = 8), MD (grey bar, n = 8) and LD (white bar, n = 8) ad-MVF-seeded Integra®, 
as assessed by immunohistochemical analysis on day 14 after implantation. Means ± SEM.
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microvessels was comparably high in all three groups. 
This proves that, even in the poorly vascularised 
LD ad-MVF-seeded implants, the vessel segments 
survived throughout the 14 d implantation period. 
On the other hand, this finding shows that less GFP- 
microvessels of the surrounding host tissue invaded 
the matrices of this group. This positive correlation 
between a low ad-MVF seeding density and a 
reduced ingrowth of blood vessels may be explained 
by decreased levels of pro-angiogenic growth factors, 
such as vascular endothelial growth factor (VEGF) 
and basic fibroblast growth factor (bFGF), within the 
implants. In fact, isolated ad-MVF have previously 
been shown to release relevant amounts of these 
factors, which may markedly contribute to their high 
angiogenic activity after in vivo implantation (Laschke 
et al., 2012). In this context, it should be considered 
that there is also a close link between angiogenesis 
and inflammation (Fiedler et al., 2006; DiPietro, 2016). 
Several studies have reported that pro-angiogenic 
factors can act as chemokines for the recruitment of 
immune cells (Khoury and Ziyadeh, 2011; Barbay 
et al., 2015). Accordingly, we detected relatively 
large numbers of MPO+ neutrophilic granulocytes, 
CD68+ macrophages and CD3+ lymphocytes in HD 
and MD ad-MVF-seeded Integra®. Since immune 
cell infiltration is a key event in wound healing 
(Reinke and Sorg, 2012) and adequate biomaterial 
integration (Anderson et al., 2008), this may have 
further contributed to the improved incorporation of 
HD and MD ad-MVF-seeded implants, which finally 
exhibited a higher collagen content and increased 
surface epithelialisation, when compared to LD ad-
MVF-seeded Integra®.
Conclusions
This study demonstrates that a reduction from 120,000 
to 80,000 ad-MVF/cm² Integra® does not affect the 
implant’s vascularisation and incorporation. These 
novel findings underline the high vascularisation 
potential of ad-MVF and indicate that 33 % less 
adipose tissue is required for the isolation of ad-MVF 
needed for a rapid and sufficient vascularisation of 
the implanted Integra®. Under clinical conditions, 
this may be particularly relevant for the treatment 
of patients with extensive skin defects and/or limited 
availability of fat tissue.
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the human body regarding the quality/usability of 
the fat for the isolation of microvascular fragments. 
Under clinical conditions, the fat harvesting zone 
may even be individually chosen according to the 
specific needs of the patient. In most cases it may be 
liposuctioned fat from the abdominal wall.
Editor note: The scientific editor for this paper was 
Chris Evans.
Discussion with Reviewers
Daniel Schmauss: Do you think there might be 
differences between the fat harvesting zones of the 
human body (e.g. abdomen, thigh, flanks) regarding 
the quality/usability of the fat for microvascular 
fragments?
Authors: Subcutaneous white fat tissue generally 
exhibits a dense vascularisation. Hence, although 
not further analysed so far, there may be no marked 
variations between different fat harvesting zones of 
